SUMMIT THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.77 USD | -3.00% |
|
-2.14% | +197.70% |
| 06-24 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer | CI |
| 06-24 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUMMIT THERAPEUTICS INC. | Bio Therapeutic Drugs | -3.00% | -2.14% | +197.70% | +214.57% | +463.04% | 5.45B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SMMT Stock
- Charts Summit Therapeutics Inc.
- Comparison Chart
